NAMI
IMNM icon

Nomura Asset Management International’s Immunome IMNM Stock Holding History

Nomura Asset Management International’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87M Buy
135,451
+38,311
+39% +$820K ﹤0.01% 979
2026
Q1 		$2.12M Buy
97,140
+14,563
+18% +$324K ﹤0.01% 956
2025
Q4 		$1.77M Buy
+82,577
New +$1.45M ﹤0.01% 1015

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Nomura Asset Management International's IMNM Position: Q2 2026 in Review

Nomura Asset Management International increased its Immunome (IMNM) stake by 39% in Q2 2026, buying an estimated $820K and bringing the position to 135,451 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Nomura Asset Management International first reported a position in IMNM in Q4 2025 and has held it in 3 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Nomura Asset Management International held 135,451 shares of Immunome worth $2.87M as of Q2 2026.
  • Nomura Asset Management International bought 38,311 Immunome shares in Q2 2026, an estimated $820K.
  • Immunome made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #979 holding.
  • Nomura Asset Management International first reported a position in Immunome in Q4 2025 and has held it in 3 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.